TS-2021 is a third-generation oncolytic adenovirus that can efficiently target glioblastoma cells overexpressing Ki67 (proliferation marker) and TGF-β2 and can inhibit invasiveness through targeting of the MKK4/JNK/MMP3 pathway (199). Here, TGFB2 is linked to glioblastoma.